Lamivudine Teva Pharma B.V.

Lamivudine, the active ingredient in Lamivudine Teva Pharma B.V., is a nucleoside reverse transcriptase inhibitor presented as an oral tablet for oral use. It treats human immunodeficiency virus (HIV) infection and chronic hepatitis B infection in adults and children as prescribed by a healthcare professional.

GNH USA supplies Lamivudine Teva Pharma B.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamivudine is used to manage viral infections that involve reverse transcriptase activity, primarily in the HIV and hepatitis B disease families. - Human immunodeficiency virus (HIV) infection: reduces viral load and helps restore immune function. - Chronic hepatitis B infection: suppresses viral replication and lowers liver inflammation. - HIV‑1 infection in combination therapy: enhances overall antiretroviral efficacy when used with other agents.

Lamivudine may cause a range of adverse reactions, from mild to severe, which should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: occasional tension‑type headaches. - Fatigue: general tiredness or weakness. - Diarrhea: loose stools, usually transient.

Serious or Rare Side Effects: - Lactic acidosis: rare metabolic complication requiring immediate medical attention. - Severe hepatotoxicity: liver enzyme elevations or hepatitis. - Pancreatitis: inflammation of the pancreas with abdominal pain. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating lamivudine therapy, several safety considerations should be observed. - Monitor liver function: obtain baseline tests and repeat periodically. - Assess renal function: adjust dosing in patients with impaired kidney function. - Avoid use in patients with known hypersensitivity: discontinue if allergic reaction occurs. - Use caution in pregnancy: limited data, weigh benefits against potential risks. - Store at room temperature: keep in the original pack, protect from moisture.

Lamivudine can interact with other medications, affecting efficacy or safety.

Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis. - Stavudine: heightened mitochondrial toxicity. - Zidovudine: additive bone‑marrow suppression.

Moderate Interactions (Monitor Closely): - Efavirenz: may require dose adjustment. - Tenofovir: monitor renal function closely. - Ribavirin: watch for enhanced anemia risk.